No, Discontinuing Latuda Does Not Cause Viral Infections
Stopping Latuda (lurasidone) does not directly cause viral infections. The medication is an atypical antipsychotic used for schizophrenia and bipolar depression, and its discontinuation does not compromise immune function or increase susceptibility to viral pathogens.
What the Evidence Shows
The FDA drug label for Latuda lists viral infections (including nasopharyngitis, influenza, and upper respiratory tract infections) as adverse events that occurred during active treatment, not after discontinuation 1. In clinical trials:
- Viral infections occurred in 10-11% of adolescents taking Latuda versus 6% on placebo
- These infections happened while patients were on the medication, not after stopping it
- The infections were common upper respiratory viruses that occur in the general population
Why This Confusion May Arise
The provided evidence discusses viral reactivation after stopping antiviral medications (for hepatitis B, HIV, and other viral diseases), not antipsychotic medications 2, 3, 4, 5, 6. These are completely different drug classes treating different conditions:
- Antiviral drugs suppress active viral infections; stopping them can allow viral rebound
- Antipsychotics like Latuda treat psychiatric conditions and do not suppress viruses
One theoretical study suggests that discontinuing antiviral drugs (not antipsychotics) may lead to viral rebound when immunity weakens during treatment 7, but this mechanism does not apply to Latuda.
What Actually Happens When Stopping Latuda
When discontinuing Latuda, the primary concerns are:
- Psychiatric symptom recurrence (return of psychosis, mania, or depression)
- Withdrawal effects (insomnia, agitation, anxiety)
- Extrapyramidal symptoms may persist or resolve
There is no immunosuppressive effect from Latuda that would predispose to infections upon discontinuation.
Clinical Bottom Line
If you develop a viral infection after stopping Latuda, it is coincidental timing, not causally related to the medication discontinuation. The infection should be managed according to standard protocols for that specific viral illness. Any decision to restart or continue Latuda should be based on psychiatric indications, not infection concerns.